FIELD: biotechnology, genetic engineering, molecular biology, pharmacy.
SUBSTANCE: invention can be used for modulating effect of ligand FAS-R or TNF on cells. Polypeptide that is able to bind with MORT-1 and exert on intracellular process of signal transfer initiating by binding ligand FAS with its receptor or by binding TNF with p55-TNF-R is prepared by culturing cells transformed with vector comprising DNA encoding polypeptide. Modulation of effect of ligand FAS-R or TNF on cells or modulation of MORT-1-induced effect is carried out using polypeptide binding with MORT-1, or a nucleotide sequence encoding thereof. Pharmaceutical composition for modulating effect of ligand FAS-R or TNF on cells comprises polypeptide binding with MORT-1. Invention allows carrying out the development of agents for treatment of tumor or HIV-infected cells.
EFFECT: improved methods for treatment, isolation and identification of proteins, valuable biological and medicinal properties of polypeptide.
55 cl, 37 dwg, 4 tbl, 3 ex
Title |
Year |
Author |
Number |
DNA MOLECULE ENCODING POLYPEPTIDE ABLE TO BIND WITH INTRACELLULAR DOMAIN OF FAS (FAS-IC) LIGAND RECEPTOR, POLYPEPTIDE, METHOD FOR ITS PREPARING, VECTOR, METHOD FOR MODULATION OF EFFECT OF FAS-R LIGAND ON CELLS (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD FOR ISOLATION AND IDENTIFICATION OF PROTEIN |
1995 |
- Uollakh Dehvid
- Boldin Mark
- Varfolomeev Evgenij
- Mett Igor'
|
RU2241747C2 |
POLYPEPTIDE POSSESSING CAPACITY FOR BINDING WITH INTRACELLULAR DOMAIN p-55 OF TNF-RECEPTOR, DNA MOLECULE ENCODING THIS POLYPEPTIDE, EXPRESSION VECTOR AND METHOD FOR PREPARING POLYPEPTIDE |
1995 |
- Vallakh David
- Boldin Mark
- Mett Igor'
- Varfolomeev Evgenij
|
RU2273664C2 |
IL-1 BINDING PROTEINS |
2011 |
- Vu Chenbin
- Ambrozi Dominik Dzh.
- Siekh Chun-Min
- Gkhayur Tarik
|
RU2615173C2 |
POLYPEPTIDES OF DIRECTED ACTION |
2006 |
- Rozenbljum Majkl G.
- Cheung Lorens
- Liu Mi-Ae
|
RU2393874C2 |
METHOD OF IDENTIFICATION OF PROTEIN ANCHOR FUNCTION INHIBITOR AND METHOD OF ASSAY PRESENCE CALCINEURINE-BINDING AND PROTEIN KINASE-BINDING ANCHOR PROTEIN IN CELL |
1995 |
- Lokerbi Robert Ouehn
- Kaflen Vinsent M.
- Khauehrd Monik L.
- Gehllatin Uil'Jam M.
- Skott Dzhon D.
|
RU2185441C2 |
POLYPEPTIDE AND IMMUNE MODULATION |
2014 |
- Kelli Deniz
- Patterson Andzhela
- Monne Eduar
- Malder Imke
|
RU2682651C2 |
BISPECIFIC BINDING AGENTS FOR MODULATING BIOLOGICAL ACTIVITY |
2005 |
- Nilsen Ulrik B.
- Shoehberl' Birgit M.
|
RU2433831C2 |
POLYPEPTIDE-LIGAND FLT3 (VARIANTS), POLYNUCLEOTIDE (VARIANTS), EXPRESSING VECTOR (VARIANTS), STRAIN OF CELL CHO (VARIANTS), METHOD FOR PRODUCING POLYPEPTIDE-LIGAND FLT3 (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) |
1994 |
- Lajmehn Stjuart D.
- Bekmann M. Patritsija
|
RU2220979C2 |
SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION |
2007 |
- Tompson Piter Armstrong
- Ledbehttehr Dzheffri A.
- Khajdehn-Ledbehttehr Marta S'Juzan
- Grosmehjr Laura S'Ju
- Bader Robert
- Brehdi Uill'Jam
- Chistjakova Ljudmila
- Folletti Maksimillian T.
- Kalabro Valeri
- Shuler Aluin
|
RU2487888C2 |
PROAPOPTOSIS PROTEINS-CONTAINING THERAPEUTIC AGENTS |
2002 |
- Rozenbljum Majkl G.
- Liu Jujing
|
RU2319709C2 |